Sage Journals: Discover world-class research

Open access

Research article

First published 2024

TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy

Aditya Bardia, Lajos Pusztai, Kathy Albain [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2025-6

Targeted therapy in TNBC: Exploring the role of antibody-drug conjugates with a focus on sacituzumab govitecan

Nahida Siddiqui, Moduru Tejo Arun, Kummari Aparna [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2005-8

Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies

Serengulam V. Govindan, Gary L. Griffiths, Hans J. Hansen [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 1991-6

Synthetic Polymers Conjugated to Monoclonal Antibodies: Vehicles for Tumour-Targeted Drug Delivery

Len W. Seymour, Pauline A. Flanagan, Aymen Al-Shamkhani [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Review article

First published 2024

Use of Antibody–Drug Conjugates in the Early Setting of Breast Cancer

Chrysanthi Koukoutzeli, Dario Trapani, Liliana Ascione [...]

Clinical Medicine Insights: Oncology

Retricted access

Review article

First published 2022-10

Role of sacituzumab govitecan in solid tumors

Sindhusha Veeraballi, Zaineb Khawar, Hafiz Muhammad Aslam [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2008-10

Multimodal Cancer Treatment: Real Time Monitoring,Optimization,and Synergistic Effects

Gunnar Myhr

Technology in Cancer Research & Treatment

Open access

Review article

First published 2022

Emerging perioperative therapeutic approaches in muscle invasive bladder cancer

Goutham Patil, Arnab Basu

Therapeutic Advances in Urology

Open access

Review article

First published 2024

Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options

Sarah K Premji, Ciara C O’Sullivan

Breast Cancer: Basic and Clinical Research

Open access

Review article

First published 2025

Recent advances of antibody-drug conjugates in treating breast cancer with different HER2 status

Yue Qiu, Yaqin Shi, Zhujun Chao [...]

Therapeutic Advances in Medical Oncology

Search results